Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 60 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8962663

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  2. US 8962631

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  3. US 8962637

    Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

    Aurigene Discovery Technologies Limited · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  4. US 8962835

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  5. US 8957078

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  6. US 8957066

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  7. US 8957031

    Competitive inhibitors of invariant chain expression and/or ectopic clip binding

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  8. US 8951964

    Phenanthridine macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  9. US 8951998

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  10. US 8940688

    Fluorinated tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  11. US 8940773

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  12. AU 2013283318

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    4SC DISCOVERY GMBH [DE] · Granted Jan 22, 2015 · Expires Jan 17, 2035

    granted

  13. US 8936781

    Macrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  14. US 8937064

    Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  15. US 8937093

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  16. US 8933080

    Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  17. US 8933110

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  18. US 8933201

    Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  19. US 8927709

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  20. US 8927730

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Northwestern University · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  21. US 8921372

    Inhibitors of hepatitis C virus

    Theravance Biopharma R&D IP, LLC · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  22. US 8921358

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  23. US 8921376

    Pyrrolopyridines useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  24. US 2014378455

    NEW USE OF 1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

    ACRAF [IT] · Granted Dec 25, 2014 · Expires Dec 20, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.